|Scientific Advisory Committee|
Seno Medical’s Scientific Advisory Committee will be comprised of experts in the field of breast cancer and will be actively involved in such aspects as the needs that drive the market for change; input into the formation of focus groups for product analysis and commentary; site participation with the approval of the product applications; and input into the protocol design for the clinical test sites.
To date, we are pleased to include the following on this important committee:
Robert Kramer, M.D., Chairman
Robert Kramer, M.D., Chairman
Dr. Kramer has extensive experience and knowledge in biotechnology and medical device commercialization. He was the national medical director of the healthcare consulting division of Coopers & Lybrand and in this capacity had his initial introduction to the business of the life science industry. Dr. Kramer is a member of the Board of Directors and Advisory Boards of several early-stage life science companies, and is a member of the External Advisory Committee of the Department of Biomedical Engineering at the University of Texas, Austin.
Thomas Budinger, M.D., Ph.D.
Dr. Budinger holds concurrent positions at the University of California, Berkeley (UCB), the University of California, San Francisco (UCSF), and the Lawrence Berkeley National Laboratory (LBNL). At UCSF, he has been professor of radiology since 1984, and served as director of the Magnetic Resonance Science Center (1993-97). At UCB, he has held the Henry Miller Research Medicine Chair (1974-present) and he has been professor of bioinstrumentation, electrical engineering, and computer sciences since 1976. In 2004 he completed a six-year appointment as founding chair of the department of bioengineering at Berkeley. Dr. Budinger holds leadership positions at Lawrence Livermore National Laboratory including: Head, Research Medicine Group (1976-1986): LBNL Medical Research Division Director (1986-1992), Head, Center for Functional Imaging (1992-2007), and Faculty Senior Staff Scientist (1986-present).
Dr. Budinger has authored over 370 research papers and book chapters and is the recipient of many awards including The Berkeley Citation National Institute of Health’s Merit Award-Alzheimer’s Research; Distinguished Scientist Silver Medal Award from the International Society for Magnetic Resonance in Medicine; George Charles de Hevesy Nuclear Pioneer Award and Paul C. Aebersold Basic Science Award from the Society of Nuclear Medicine, and the Ernst Jung Preis fur Medizin, Jung-Stiftung fur Wissenschaft und Forschung, Germany.
Charles Coltman, M.D., President Emeritus of the Cancer Therapy & Research Center (CTRC)
Coltman has a long history in cancer research and began his tenure at the University of Texas, San Antonio, Cancer Therapy Research Center (CTRC) in 1974, and ultimately became President/CEO. In 1978, while at CTRC, Coltman became one of two co-founders of the San Antonio Breast Cancer Symposium, which has grown exponentially to become the world's leading symposium devoted to breast cancer. Under Coltman's leadership, the CTRC, which began as a regional radiotherapy center, developed into a nationally-recognized research and therapy center and now includes the Institute for Drug Development, an organization which conducts more Phase I clinical trials for cancer than any other location in the world.
Previously Chair of Department of Physiology-Pharmacology at the University of Georgia, Dr. Crawford has also been Administrator of the Food Safety and Inspection Service (USDA) and Director of the Center for Food and Nutrition Policy from 1997 to 2002, first at Georgetown University and at Virginia Tech, where it moved in 2001. He is a Member of the National Academy of Sciences Institute of Medicine, a Fellow of the Royal Society of Medicine (UK) and a Fellow of the International Society of Food Science and Technology. In 1984, he was inducted into the French Academy of Veterinary Medicine and in 1991 he received the Wooldridge Award, the British Veterinary Association’s highest award.
Dr. Crawford received his Doctor of Veterinary Medicine from Auburn University, his PhD in Pharmacology from the University of Georgia and his Honorary Doctorate (MDV) from Budapest University.
John Holaday, Ph.D.
Prior to joining Reliant Pharmaceuticals, Dr. Keane worked with Merck & Co., Inc., as Vice President, Clinical Development and served as Vice President, U.S. Medical & Scientific Affairs from 2004 until his retirement in 2007. Dr. Keane’s responsibilities in the U.S. included post-registration clinical studies, data base analysis studies, external scientific collaborations and medical affairs. Dr. Keane, has had a distinguished medical career, serving as Chairman of the Department of Medicine at Hennepin Medical Center in Minneapolis, Minnesota, and as the Vice Chair and Professor of Medicine and Pharmacy at the University of Minnesota Medical School. William Keane received his medical degree from Yale University School of Medicine.
Walter Robb, Ph.D.
Additional candidates are being considered for participation on the Scientific Advisory Committee.
|< Prev||Next >|